GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Series GSE52169
Query DataSets for GSE52169
Status
Public on Dec 27, 2013
Title
Glucocorticoid Receptor Confers Resistance to Anti-Androgens by Bypassing Androgen Receptor Blockade.
Organism
Homo sapiens
Experiment type
Expression profiling by array
Summary
This SuperSeries is composed of the SubSeries listed below.
Overall design
Refer to individual Series
Citation(s)
24315100
Submission date
Nov 07, 2013
Last update date
Aug 13, 2018
Contact name
Vivek Kumar Arora
Organization name
Memorial Sloan Kettering Cancer Center
Department
HOPP
Lab
Charles Sawyers
Street address
1275 York Avenue
City
New York
State/province
NY
ZIP/Postal code
10065
Country
USA
Platforms (1)
GPL10558
Illumina HumanHT-12 V4.0 expression beadchip
Samples (86)
Less...
More...
GSM1254320
Vehicle (DMSO) (ECS195_1)
GSM1254321
DHT 1nM (ECS195_2)
GSM1254322
Dex 10 nM (ECS195_4)
GSM1254323
Dex 100 nM (ECS195_5)
GSM1254324
Enzalutamide 10 micromolar (ECS195_6)
GSM1254325
Enzalutamide + DHT 1nM (ECS195_7)
GSM1254326
Enzalutamide + Dex 10nM (ECS195_9)
GSM1254327
Enzalutamide + Dex 100nM (ECS195_10)
GSM1254328
Vehicle (DMSO) (ECS195_11)
GSM1254329
DHT 1nM (ECS195_12)
GSM1254330
Dex 10 nM (ECS195_14)
GSM1254331
Dex 100 nM (ECS195_15)
GSM1254332
Enzalutamide 10 micromolar (ECS195_16)
GSM1254333
Enzalutamide + DHT 1nM (ECS195_17)
GSM1254334
Enzalutamide + Dex 10nM (ECS195_19)
GSM1254335
Enzalutamide + Dex 100nM (ECS195_20)
GSM1254336
Vehicle (DMSO) (ECS195_21)
GSM1254337
DHT 1nM (ECS195_22)
GSM1254338
Dex 10 nM (ECS195_24)
GSM1254339
Dex 100 nM (ECS195_25)
GSM1254340
Enzalutamide 10 micromolar (ECS195_26)
GSM1254341
Enzalutamide + DHT 1nM (ECS195_27)
GSM1254342
Enzalutamide + Dex 10nM (ECS195_29)
GSM1254343
Enzalutamide + Dex 100nM (ECS195_30)
GSM1254344
Veh (DMSO) - exp1091_1_1
GSM1254345
DHT 0.1 nM - exp1091_1_2
GSM1254346
Enzalutamide 10 micromolar - exp1091_1_5
GSM1254347
Enzalutamide 10 micromolar + Dexamethasone 100 nM - exp1091_1_7
GSM1254348
Veh (DMSO) - exp1091_2_1
GSM1254349
DHT 0.1 nM - exp1091_2_2
GSM1254350
Enzalutamide 10 micromolar - exp1091_2_5
GSM1254351
Enzalutamide 10 micromolar + Dexamethasone 100 nM - exp1091_2_7
GSM1254352
Veh (DMSO) - exp1091_3_1
GSM1254353
DHT 0.1 nM - exp1091_3_2
GSM1254354
Enzalutamide 10 micromolar - exp1091_3_5
GSM1254355
Enzalutamide 10 micromolar + Dexamethasone 100 nM - exp1091_3_7
GSM1254356
Con A (900L)
GSM1254357
Con A (900R)
GSM1254358
Con A (902L)
GSM1254359
Con A (903L)
GSM1254360
Con A (907L)
GSM1254361
Con A (907R)
GSM1254362
4 day (913R)
GSM1254363
4 day (910L)
GSM1254364
4 day (911L)
GSM1254365
4 day (912L)
GSM1254366
4 day (913L)
GSM1254367
4 day (914L)
GSM1254368
Res - top 50th percentile of GR expressers (915R)
GSM1254369
Res - top 50th percentile of GR expressers (917L)
GSM1254370
Res - top 50th percentile of GR expressers (918R)
GSM1254371
Res - top 50th percentile of GR expressers (919R)
GSM1254372
Res - Low GR (926R)
GSM1254373
Res - top 50th percentile of GR expressers (927L)
GSM1254374
Res - Low GR (927R)
GSM1254375
Res - top 75th percentile of GR expressers (929L)
GSM1254376
Res - Low GR (929R)
GSM1254377
Con A (909L)
GSM1254378
Res - Low GR (920L)
GSM1254379
Con A (900_25)
GSM1254380
Con A (900_26)
GSM1254381
Con A (900_27)
GSM1254382
4 day (900_28)
GSM1254383
4 day (900_29)
GSM1254384
Res - top 50th percentile of GR expressers (900_3)
GSM1254385
Res - top 50th percentile of GR expressers (900_32)
GSM1254386
Res - top 75th percentile of GR expressers (900_33)
GSM1254387
Res - top 75th percentile of GR expressers (900_34)
GSM1254388
Res - top 75th percentile of GR expressers (900_35)
GSM1254389
Res - top 50th percentile of GR expressers (900_36)
GSM1254390
Con B (1)
GSM1254391
Con B (2)
GSM1254392
Con B (3)
GSM1254393
Con B (4)
GSM1254394
LREX' (9)
GSM1254395
LREX' (10)
GSM1254396
LREX' (12)
GSM1254397
Con B (13)
GSM1254398
Con B (14)
GSM1254399
Con B (15)
GSM1254400
Con B (16)
GSM1254401
LREX' (21)
GSM1254402
LREX' (22)
GSM1254403
LREX' (23)
GSM1254404
LREX' (24)
GSM1254405
LREX' (11)
This SuperSeries is composed of the following SubSeries:
GSE51871
Androgen and Glucocorticoid stimulation of LREX' cells in vitro
GSE51872
Dexamethasone treatment of VCaP prostate cells
GSE51873
LNCAP/AR and a LnCAP/AR subline (LREX') with acquired resistance to 2nd generation antiandrogens
Relations
BioProject
PRJNA227082
Download family
Format
SOFT formatted family file(s)
SOFT
MINiML formatted family file(s)
MINiML
Series Matrix File(s)
TXT
Supplementary file
Size
Download
File type/resource
GSE52169_RAW.tar
26.2 Mb
(http)
(custom)
TAR
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|